State of Wyoming Purchases Shares of 2,427 The Clorox Company $CLX

Key Points

• The State of Wyoming invested approximately $357,000 in The Clorox Company, acquiring 2,427 shares during the first quarter according to their 13F filing with the SEC.
• Clorox recently reported earnings of $2.87 EPS for the quarter, exceeding estimates and indicating a 4.5% revenue increase compared to the previous year.
• The company has announced an increase in its quarterly dividend to $1.24, reflecting a dividend yield of 4.2%.

State of Wyoming acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,427 shares of the company's stock, valued at approximately $357,000.

A number of other hedge funds have also recently added to or reduced their stakes in CLX. Lido Advisors LLC grew its holdings in Clorox by 40.2% during the 4th quarter. Lido Advisors LLC now owns 4,475 shares of the company's stock worth $727,000 after acquiring an additional 1,282 shares during the last quarter. Comerica Bank grew its holdings in Clorox by 15.7% during the 4th quarter. Comerica Bank now owns 36,196 shares of the company's stock worth $5,879,000 after acquiring an additional 4,908 shares during the last quarter. Mercer Global Advisors Inc. ADV grew its holdings in Clorox by 1.4% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 14,206 shares of the company's stock worth $2,307,000 after acquiring an additional 201 shares during the last quarter. AlTi Global Inc. bought a new stake in Clorox during the 4th quarter worth about $212,000. Finally, AXA S.A. grew its holdings in Clorox by 114.0% during the 4th quarter. AXA S.A. now owns 91,086 shares of the company's stock worth $14,793,000 after acquiring an additional 48,524 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Trading Up 2.5%

Clorox stock traded up $2.95 during midday trading on Wednesday, hitting $122.93. 2,859,002 shares of the stock were exchanged, compared to its average volume of 1,616,459. The company has a fifty day simple moving average of $123.87 and a two-hundred day simple moving average of $133.78. The Clorox Company has a 52 week low of $116.53 and a 52 week high of $171.37. The stock has a market capitalization of $15.04 billion, a PE ratio of 18.85, a P/E/G ratio of 0.94 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same quarter last year, the firm earned $1.82 EPS. Clorox's quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th were paid a $1.24 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This is an increase from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. Clorox's payout ratio is presently 76.07%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CLX shares. UBS Group decreased their price objective on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Wells Fargo & Company lifted their price target on shares of Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. Jefferies Financial Group lowered their price target on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Barclays lowered their price target on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research report on Tuesday, July 15th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, Clorox has an average rating of "Reduce" and a consensus target price of $143.36.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.